{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T00:42:20Z","timestamp":1793580140842,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","award":["R01DK108803"],"award-info":[{"award-number":["R01DK108803"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","award":["R01DK124399"],"award-info":[{"award-number":["R01DK124399"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","award":["R01DK100446"],"award-info":[{"award-number":["R01DK100446"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","award":["R01DK115534"],"award-info":[{"award-number":["R01DK115534"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001259","name":"National Kidney Foundation","doi-asserted-by":"publisher","award":["K24 HL159246"],"award-info":[{"award-number":["K24 HL159246"]}],"id":[{"id":"10.13039\/100001259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001259","name":"National Kidney Foundation","doi-asserted-by":"publisher","award":["K24AG078506"],"award-info":[{"award-number":["K24AG078506"]}],"id":[{"id":"10.13039\/100001259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K24 HL159246"],"award-info":[{"award-number":["K24 HL159246"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K24AG078506"],"award-info":[{"award-number":["K24AG078506"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01HL096899"],"award-info":[{"award-number":["U01HL096899"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01HL096902"],"award-info":[{"award-number":["U01HL096902"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01HL096917"],"award-info":[{"award-number":["U01HL096917"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01HL096814"],"award-info":[{"award-number":["U01HL096814"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K24HL115861"],"award-info":[{"award-number":["K24HL115861"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01HL096812"],"award-info":[{"award-number":["U01HL096812"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.mayocp.2024.11.030","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T23:29:18Z","timestamp":1747438158000},"page":"1551-1562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Polypharmacy and Potentially Inappropriate Medications in Adults \u226575 Years of Age by Dementia and Frailty Status: The ARIC Study"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1572-1340","authenticated-orcid":false,"given":"Pamela L.","family":"Lutsey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Misialek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Whitsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamakshi","family":"Lakshminarayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Kucharska-Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Gwen","family":"Windham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Secora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan E.","family":"Grams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel F.","family":"Farley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mayocp.2024.11.030_bib1","doi-asserted-by":"crossref","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? a systematic review of definitions","volume":"17","author":"Masnoon","year":"2017","journal-title":"BMC Geriatr"},{"issue":"3","key":"10.1016\/j.mayocp.2024.11.030_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020270","article-title":"Factors associated with polypharmacy in primary care: a cross-sectional analysis of data from the English Longitudinal Study of Ageing (ELSA)","volume":"8","author":"Slater","year":"2018","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.mayocp.2024.11.030_bib3","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s00392-015-0936-y","article-title":"Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial","volume":"105","author":"Proietti","year":"2016","journal-title":"Clin Res Cardiol"},{"issue":"4","key":"10.1016\/j.mayocp.2024.11.030_bib4","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCULATIONAHA.115.018544","article-title":"Polypharmacy and the efficacy and safety of rivaroxaban versus warfarin in the prevention of stroke in patients with nonvalvular atrial fibrillation","volume":"133","author":"Piccini","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.mayocp.2024.11.030_bib5","article-title":"Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial","volume":"353","author":"Jaspers","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.mayocp.2024.11.030_bib6","first-page":"1","article-title":"Prescription drug use among adults aged 40\u201379 in the United States and Canada","volume":"347","author":"Hales","year":"2019","journal-title":"NCHS Data Brief"},{"issue":"8","key":"10.1016\/j.mayocp.2024.11.030_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255642","article-title":"Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016","volume":"16","author":"Young","year":"2021","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.mayocp.2024.11.030_bib8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s40801-023-00358-2","article-title":"Risk factors associated with polypharmacy and potentially inappropriate medication use in ambulatory care among the elderly in the United States: a cross-sectional study","volume":"10","author":"Nguyen","year":"2023","journal-title":"Drugs Real World Outcomes"},{"issue":"9","key":"10.1016\/j.mayocp.2024.11.030_bib9","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/jamainternmed.2024.2781","article-title":"Prescription medication use among older adults in the US","volume":"184","author":"Innes","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.mayocp.2024.11.030_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cger.2016.01.008","article-title":"Future research directions for multimorbidity involving cardiovascular diseases","volume":"32","author":"Salive","year":"2016","journal-title":"Clin Geriatr Med"},{"issue":"1","key":"10.1016\/j.mayocp.2024.11.030_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/2042098615615472","article-title":"Predicting risk of adverse drug reactions in older adults","volume":"7","author":"Lavan","year":"2016","journal-title":"Ther Adv Drug Saf"},{"issue":"4","key":"10.1016\/j.mayocp.2024.11.030_bib12","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/bcp.12596","article-title":"Adverse drug reactions in special populations: the elderly","volume":"80","author":"Davies","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.mayocp.2024.11.030_bib14","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jama.289.9.1107","article-title":"Incidence and preventability of adverse drug events among older persons in the ambulatory setting","volume":"289","author":"Gurwitz","year":"2003","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.mayocp.2024.11.030_bib15","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1345\/aph.1H658","article-title":"Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care","volume":"41","author":"Thomsen","year":"2007","journal-title":"Ann Pharmacother"},{"issue":"8","key":"10.1016\/j.mayocp.2024.11.030_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.26910","article-title":"Prevalence of use of potentially inappropriate medications among older adults worldwide: a systematic review and meta-analysis","volume":"6","author":"Tian","year":"2023","journal-title":"JAMA Network Open"},{"issue":"4","key":"10.1016\/j.mayocp.2024.11.030_bib17","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for Potentially Inappropriate Medication Use in Older Adults","volume":"67","year":"2019","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"10.1016\/j.mayocp.2024.11.030_bib18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2174\/157488471003150820150330","article-title":"Barriers to optimising prescribing and deprescribing in older adults with dementia: a narrative review","volume":"10","author":"Reeve","year":"2015","journal-title":"Curr Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.mayocp.2024.11.030_bib19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00228-012-1387-2","article-title":"Medication prescribing in frail older people","volume":"69","author":"Hubbard","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.mayocp.2024.11.030_bib20","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/ggi.12589","article-title":"Algorithm of medication review in frail older people: focus on minimizing the use of high-risk medications","volume":"16","author":"Poudel","year":"2016","journal-title":"Geriatr Gerontol Int"},{"issue":"5","key":"10.1016\/j.mayocp.2024.11.030_bib21","doi-asserted-by":"crossref","first-page":"174","DOI":"10.18773\/austprescr.2017.055","article-title":"Prescribing for frail older people","volume":"40","author":"Hilmer","year":"2017","journal-title":"Aust Prescr"},{"issue":"9","key":"10.1016\/j.mayocp.2024.11.030_bib22","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/j.1532-5415.2005.53523.x","article-title":"Unnecessary drug use in frail older people at hospital discharge","volume":"53","author":"Hajjar","year":"2005","journal-title":"J Am Geriatr Soc"},{"issue":"23","key":"10.1016\/j.mayocp.2024.11.030_bib23","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1016\/j.jacc.2021.04.035","article-title":"The ARIC (Atherosclerosis Risk In Communities) study: JACC focus seminar 3\/8","volume":"77","author":"Wright","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.mayocp.2024.11.030_bib24","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s40266-018-0563-1","article-title":"Kidney function, polypharmacy, and potentially inappropriate medication use in a community-based cohort of older adults","volume":"35","author":"Secora","year":"2018","journal-title":"Drugs Aging"},{"key":"10.1016\/j.mayocp.2024.11.030_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.dadm.2015.12.002","article-title":"Mild cognitive impairment and dementia prevalence: the Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS)","volume":"2","author":"Knopman","year":"2016","journal-title":"Alzheimers Dement (Amst)"},{"issue":"7","key":"10.1016\/j.mayocp.2024.11.030_bib26","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1002\/alz.13876","article-title":"Patterns of cognitive domain abnormalities enhance discrimination of dementia risk prediction: the ARIC study","volume":"20","author":"Knopman","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.mayocp.2024.11.030_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/archneur.1989.00520380041011","article-title":"A verbal memory test with high predictive accuracy for dementia of the Alzheimer type","volume":"46","author":"Knopman","year":"1989","journal-title":"Arch Neurol"},{"key":"10.1016\/j.mayocp.2024.11.030_bib28","series-title":"Wechsler Adult Intelligence Scale (WAIS-III)","author":"Wechsler","year":"1997"},{"key":"10.1016\/j.mayocp.2024.11.030_bib29","series-title":"Neurosensory Center Comprehensive Examination for Aphasia: Manual of Directions. Revised Edition. Neuropsychology Laboratory. Neuropsychological Laboratory","author":"Spreen","year":"1977"},{"key":"10.1016\/j.mayocp.2024.11.030_bib30","series-title":"Wechsler Memory Scale-Revised","author":"Wechsler","year":"1987"},{"issue":"3","key":"10.1016\/j.mayocp.2024.11.030_bib31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","article-title":"Validity of the Trail Making Test as an indicator of organic brain damage","volume":"8","author":"Reitan","year":"1958","journal-title":"Percept Mot Skills"},{"key":"10.1016\/j.mayocp.2024.11.030_bib32","series-title":"Boston Naming Test","author":"Kaplan","year":"1983"},{"issue":"1","key":"10.1016\/j.mayocp.2024.11.030_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0028-3932(68)90038-9","article-title":"Differential behavioral effects in frontal lobe disease","volume":"6","author":"Benton","year":"1968","journal-title":"Neuropsychologia"},{"issue":"3","key":"10.1016\/j.mayocp.2024.11.030_bib34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"issue":"3","key":"10.1016\/j.mayocp.2024.11.030_bib35","first-page":"382","article-title":"Operationalizing frailty in the Atherosclerosis Risk in Communities study cohort","volume":"72","author":"Kucharska-Newton","year":"2017","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"10.1016\/j.mayocp.2024.11.030_bib36","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"10.1016\/j.mayocp.2024.11.030_bib39","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1161\/CIR.0000000000000579","article-title":"Health literacy and cardiovascular disease: fundamental relevance to primary and secondary prevention: a scientific statement from the American Heart Association","volume":"138","author":"Magnani","year":"2018","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.mayocp.2024.11.030_bib40","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/CIRCRESAHA.121.319811","article-title":"Social determinants of cardiovascular disease","volume":"130","author":"Powell-Wiley","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.mayocp.2024.11.030_bib41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/epirev\/mxs009","article-title":"Multimorbidity in older adults","volume":"35","author":"Salive","year":"2013","journal-title":"Epidemiol Rev"},{"issue":"17","key":"10.1016\/j.mayocp.2024.11.030_bib42","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in prescription drug use among adults in the United States from 1999-2012","volume":"314","author":"Kantor","year":"2015","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.mayocp.2024.11.030_bib43","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1111\/jgs.17291","article-title":"Polypharmacy among older adults with dementia compared with those without dementia in the United States","volume":"69","author":"Growdon","year":"2021","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"10.1016\/j.mayocp.2024.11.030_bib44","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1001\/jama.2021.1195","article-title":"Prevalence of central nervous system\u2013active polypharmacy among older adults with dementia in the US","volume":"325","author":"Maust","year":"2021","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.mayocp.2024.11.030_bib45","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1093\/gerona\/glad178","article-title":"Bidirectional association between multimorbidity and frailty and the role of depression in older Europeans","volume":"78","author":"Feng","year":"2023","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.mayocp.2024.11.030_bib46","doi-asserted-by":"crossref","DOI":"10.2196\/45848","article-title":"Contribution of frailty to multimorbidity patterns and trajectories: longitudinal dynamic cohort study of aging people","volume":"9","author":"Carrasco-Ribelles","year":"2023","journal-title":"JMIR Public Health Surveill"},{"issue":"6","key":"10.1016\/j.mayocp.2024.11.030_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0285923","article-title":"Medium and long-term prognosis in hospitalised older adults with multimorbidity: a prospective cohort study","volume":"18","author":"Molina","year":"2023","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.mayocp.2024.11.030_bib48","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cger.2010.08.006","article-title":"The biology of aging and frailty","volume":"27","author":"Fedarko","year":"2011","journal-title":"Clin Geriatr Med"},{"issue":"2","key":"10.1016\/j.mayocp.2024.11.030_bib49","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jamda.2019.10.022","article-title":"Adverse outcomes of polypharmacy in older people: systematic review of reviews","volume":"21","author":"Davies","year":"2020","journal-title":"J Am Med Directors Assoc"},{"issue":"12","key":"10.1016\/j.mayocp.2024.11.030_bib50","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1111\/jgs.13153","article-title":"Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review","volume":"62","author":"Fried","year":"2014","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"10.1016\/j.mayocp.2024.11.030_bib51","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.amjmed.2020.12.008","article-title":"Assessing the impact of comprehensive medication management on achievement of the quadruple aim","volume":"134","author":"McFarland","year":"2021","journal-title":"Am J Med"},{"key":"10.1016\/j.mayocp.2024.11.030_bib52","author":"McInnis"},{"key":"10.1016\/j.mayocp.2024.11.030_bib53","author":"Barr"},{"issue":"10","key":"10.1016\/j.mayocp.2024.11.030_bib54","first-page":"1337","article-title":"Medication therapy problem documentation and reporting: a review of the literature and recommendations","volume":"4","author":"Armistead","year":"2021","journal-title":"JACCP"},{"key":"10.1016\/j.mayocp.2024.11.030_bib55","author":"Chavez-Valdez"},{"key":"10.1016\/j.mayocp.2024.11.030_bib56","first-page":"857","article-title":"Methods to reduce prescribing errors in elderly patients with multimorbidity","volume":"11","author":"Lavan","year":"2016","journal-title":"Clin Interv Aging"},{"issue":"2","key":"10.1016\/j.mayocp.2024.11.030_bib57","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cger.2017.01.007","article-title":"Polypharmacy reduction strategies: tips on incorporating American Geriatrics Society Beers and Screening Tool of Older People's Prescriptions criteria","volume":"33","author":"Levy","year":"2017","journal-title":"Clin Geriatr Med"},{"issue":"11","key":"10.1016\/j.mayocp.2024.11.030_bib58","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1007\/s11606-020-06089-2","article-title":"Deprescribing for community-dwelling older adults: a systematic review and meta-analysis","volume":"35","author":"Bloomfield","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1016\/j.mayocp.2024.11.030_bib59","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1186\/s13063-020-04482-0","article-title":"The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial","volume":"21","author":"Bayliss","year":"2020","journal-title":"Trials"},{"issue":"5","key":"10.1016\/j.mayocp.2024.11.030_bib60","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/jamainternmed.2022.0502","article-title":"Deprescribing education vs usual care for patients with cognitive impairment and primary care clinicians: the OPTIMIZE pragmatic cluster randomized trial","volume":"182","author":"Bayliss","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"11","key":"10.1016\/j.mayocp.2024.11.030_bib61","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/jamainternmed.2020.2750","article-title":"Representation of older adults in cardiovascular disease trials since the inclusion across the lifespan policy","volume":"180","author":"Nanna","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"11","key":"10.1016\/j.mayocp.2024.11.030_bib62","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1001\/jamainternmed.2020.2735","article-title":"Inclusion across the lifespan in cardiovascular trials\u2014a long road ahead","volume":"180","author":"DeJong","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"15","key":"10.1016\/j.mayocp.2024.11.030_bib64","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1001\/jama.2018.12368","article-title":"Inclusion across the lifespan: NIH policy for clinical research","volume":"320","author":"Bernard","year":"2018","journal-title":"JAMA"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619624006670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619624006670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:14:12Z","timestamp":1777425252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619624006670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":60,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0025619624006670"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2024.11.030","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polypharmacy and Potentially Inappropriate Medications in Adults \u226575 Years of Age by Dementia and Frailty Status: The ARIC Study","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2024.11.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}